View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| ONDCP | RIN: 3201-AA01 | Publication ID: Spring 2020 |
| Title: ●FOIA Improvements Act Update and Privacy | |
|
Abstract:
ONDCP is updating its FOIA regulation pursuant to the FOIA Improvements Act of 2016. We are amending our existing FOIA regulation to meet the requirements of the FOIA Improvements Act. ONDCP is also promulgating our agency Privacy Act regulation. ONDCP is promulgating Privacy Act implementing regulations to establish formal procedures for requesting information protected by the Privacy Act. |
|
| Agency: Office of National Drug Control Policy(ONDCP) | Priority: Other Significant |
| RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: No | Unfunded Mandates: No |
| EO 14192 Designation: Regulatory | |
| CFR Citation: 21 CFR 1401 | |
| Legal Authority: 5 U.S.C. 552 5 U.S.C. 552a | |
|
Legal Deadline:
None |
|||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
| Small Entities Affected: No | Federalism: No |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Anthony Jones Acting General Counsel Office of National Drug Control Policy 1800 G Street NW, Washington, DC 20503 Phone:202 395-3493 Email: anthony.d.jones2@ondcp.eop.gov Michael J. Passante Acting General Counsel Office of National Drug Control Policy 1800 G Street NW., Washington, DC 20503 Phone:202 395-6709 Email: michael.j.passante@ondcp.eop.gov |
|
An official website of the United States government




